Cargando…
PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas
The self-renewal transcription factor Nanog and the phosphoinositide 3-kinase (PI3K)–Akt pathway are known to be essential for maintenance of mesenchymal stem cells. We evaluated their contribution to the maintenance of CD133(+) cancer stem-like cells (CSCs) and spheroid-forming cells in patient-der...
Autores principales: | Yoon, Changhwan, Lu, Jun, Yi, Brendan C., Chang, Kevin K., Simon, M. Celeste, Ryeom, Sandra, Yoon, Sam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815726/ https://www.ncbi.nlm.nih.gov/pubmed/33468992 http://dx.doi.org/10.1038/s41389-020-00300-z |
Ejemplares similares
-
PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance
por: Yoon, Changhwan, et al.
Publicado: (2021) -
Platelet-derived growth factor receptor-α and -β promote cancer stem cell phenotypes in sarcomas
por: Chang, Kevin K., et al.
Publicado: (2018) -
Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy
por: Yoon, Changhwan, et al.
Publicado: (2016) -
PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
por: Almozyan, Sheema, et al.
Publicado: (2017) -
E-cadherin and K-ras: implications of a newly developed model of gastric cancer
por: Till, Jacob E., et al.
Publicado: (2017)